Keyphrases
Atopic Dermatitis
100%
Systemic Sclerosis
42%
Melanoma
36%
Psoriasis
29%
Cutaneous T-cell Lymphoma
24%
Dermatologist
21%
Epidermis
20%
United States
20%
Keratinocytes
20%
Vitiligo
19%
Scleroderma
19%
Eczema
18%
Transforming Growth Factor-β
17%
Tumor
16%
Mycosis Fungoides
16%
Moderate-to-severe Atopic Dermatitis
15%
Skin Cancer
14%
Melanocytes
14%
Confidence Interval
14%
Fibrosis
13%
Clinical Trials
13%
Itch
13%
Randomized Controlled Trial
13%
T Cells
13%
Placebo
12%
Quality of Life
12%
Dupilumab
12%
Pediatric Patients
12%
Adverse Events
12%
Fibroblasts
11%
Melanocytic Nevus
11%
Dermatologic Surgery
11%
Metastatic Melanoma
11%
Mohs Micrographic Surgery
11%
Moderate-to-severe Psoriasis
10%
Topical Corticosteroids
10%
Severity Index
10%
Skin Diseases
10%
Cadherin
10%
Area Index
9%
Pruritus
9%
Pediatric
9%
Inflammation
9%
Phase II Trial
9%
Clinical Features
8%
Epidermolysis Bullosa
8%
Odds Ratio
8%
Sun Protection
8%
Topical Therapy
8%
Meta-analysis
8%
Interferon-α (IFN-α)
7%
Basal Cell Carcinoma
7%
Non-melanoma Skin Cancer
7%
Randomized Clinical Trial
7%
Moderate to Severe
7%
Skin Fibroblasts
7%
Comorbidity
7%
Histopathological Features
7%
Skin Color
7%
Immune Response
6%
Fluorescence in Situ Hybridization
6%
Scar
6%
Gene Expression
6%
Desmosome
6%
Patient-Reported Outcomes Measurement Information System (PROMIS)
6%
Squamous Cell Carcinoma (SqCC)
6%
Disease Severity
6%
Dermatological Diseases
6%
Ichthyosis
6%
Systematic Meta-analysis
6%
Psoriasis Severity
6%
Systemic Therapy
6%
Asthma
5%
Acne
5%
Laser Therapy
5%
Desmoglein
5%
Human Skin
5%
Apoptosis
5%
Gangliosides
5%
Adhesion
5%
Glucocorticoid Receptor
5%
Surgeons
5%
US Adults
5%
High Risk
5%
Psoriasis Treatment
5%
Pediatric Atopic Dermatitis
5%
Melanoma Cells
5%
Risk Factors
5%
Inflammatory Skin Diseases
5%
Dermatitis
5%
Nevus
5%
Adverse Drug Events
5%
Phase II Study
5%
Skin Biopsy
5%
E-cadherin
5%
Sun Exposure
5%
Erythema
5%
Monoclonal Antibody
5%
Treatment Options
5%
Malignancy
5%
Medicine and Dentistry
Atopic Dermatitis
61%
Melanoma
49%
Neoplasm
37%
Diseases
35%
Psoriasis
26%
Systemic Scleroderma
25%
Dermatology
25%
Systematic Review
18%
Pediatrics
18%
Dermatological Agent
18%
Cutaneous T Cell Lymphoma
17%
Adverse Event
17%
Dermatosis
16%
Skin Cancer
16%
Vitiligo
15%
Pruritus
14%
Malignant Neoplasm
14%
Quality of Life
14%
Mycosis fungoides
14%
Diseases
14%
Cosmetics
13%
Melanocyte
13%
Scleroderma
12%
Biopsy Technique
11%
Clinical Trial
11%
Fibroblast
11%
Mohs Surgery
11%
Keratinocyte
10%
Eczema
10%
Fibrosis
10%
T Cell
10%
Acneiform Eruption
10%
Randomized Controlled Trial
10%
Infection
10%
Dermatitis
10%
Placebo
9%
Patient-Reported Outcome
9%
Cancer Growth Factor
9%
Skin Surgery
9%
Nevus
9%
Disease
8%
Prevalence
8%
Topical Corticosteroid
8%
Cross Sectional Study
8%
Clinician
8%
Cancer
8%
Surgeon
7%
Sun Protection
7%
Pediatrics Patient
7%
Health Care Cost
7%
Squamous Cell Carcinoma
7%
Fluorescence in Situ Hybridization
7%
In Vitro
7%
Metastatic Carcinoma
7%
Comorbidity
7%
Gene Expression
7%
Morphology
7%
Recurrent Disease
7%
Neck
7%
Stem Cell
7%
Systemic Therapy
6%
Basal-Cell Carcinoma
6%
Scar Formation
6%
Biological Product
6%
Melanoma Skin Cancer
6%
Ichthyosis
6%
Spitz Nevus
6%
Dupilumab
6%
Topical Treatment
6%
Odds Ratio
5%
Skin Defect
5%
Psoriasis Vulgaris
5%
Cutaneous Lymphoma
5%
Low Level Laser Therapy
5%
Non Melanoma Skin Cancer
5%
Randomized Clinical Trial
5%
Erythema
5%
Skin Biopsy
5%
Diagnosis
5%
Lung
5%
Side Effect
5%
Immunotherapy
5%
Cytokine
5%
Meta-Analysis
5%
Immunohistochemistry
5%
Phototherapy
5%
Oncology
5%